These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7891044)

  • 1. Human somatic gene therapy: progress and problems.
    Brenner MK
    J Intern Med; 1995 Mar; 237(3):229-39. PubMed ID: 7891044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
    Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
    Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for haematopoietic and lymphoid disorders.
    Kohn DB
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():54-7. PubMed ID: 9020937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer into haemopoietic cells.
    Stocking C; Baum C
    Baillieres Clin Haematol; 1997 Sep; 10(3):445-65. PubMed ID: 9421610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer. A potential approach to gene therapy for sickle cell disease.
    Bank A; Markowitz D; Lerner N
    Ann N Y Acad Sci; 1989; 565():37-43. PubMed ID: 2672970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten years of gene therapy for primary immune deficiencies.
    Aiuti A; Roncarolo MG
    Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer into human hematopoietic progenitor cells: a review of current clinical protocols.
    Brenner MK
    J Hematother; 1993; 2(1):7-17. PubMed ID: 7522875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow.
    Fairbairn LJ; Lashford LS; Spooncer E; McDermott RH; Lebens G; Arrand JE; Arrand JR; Bellantuono I; Holt R; Hatton CE; Cooper A; Besley GT; Wraith JE; Anson DS; Hopwood JJ; Dexter TM
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2025-30. PubMed ID: 8700879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of marker gene studies to hemopoietic stem cell therapies.
    Brenner MK
    Stem Cells; 1995 Sep; 13(5):453-61. PubMed ID: 8528094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer into hematopoietic cells: progress, problems and prospects.
    Dilber MS
    Turk J Pediatr; 1998; 40(3):307-36. PubMed ID: 9763896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA
    Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
    Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
    Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer into murine hematopoietic stem cells and bone marrow stromal cells.
    Luskey BD; Lim B; Apperley JF; Orkin SH; Williams DA
    Ann N Y Acad Sci; 1990; 612():398-406. PubMed ID: 2291566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy.
    Cartier N; Hacein-Bey-Abina S; Bartholomae CC; Bougnères P; Schmidt M; Kalle CV; Fischer A; Cavazzana-Calvo M; Aubourg P
    Methods Enzymol; 2012; 507():187-98. PubMed ID: 22365775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy.
    Bernardo ME; Aiuti A
    Hum Gene Ther; 2016 Oct; 27(10):741-748. PubMed ID: 27530055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer into hematopoietic progenitor and stem cells: progress and problems.
    Dunbar CE; Emmons RV
    Stem Cells; 1994 Nov; 12(6):563-76. PubMed ID: 7881358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of HIV vectors for anti-HIV gene therapy.
    Poeschla E; Corbeau P; Wong-Staal F
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11395-9. PubMed ID: 8876146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.